EAM
EFG Asset Management Portfolio holdings
AUM
$708M
This Quarter Return
+24.17%
1 Year Return
+34.17%
3 Year Return
+178.74%
5 Year Return
–
10 Year Return
–
AUM
$708M
AUM Growth
+$708M
(+18%)
Cap. Flow
-$3.53M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
19.86%
Holding
191
New
15
Increased
88
Reduced
58
Closed
30
Top Buys
| 1 |
Modine Manufacturing
MOD
|
$4.2M |
| 2 |
Cadence Design Systems
CDNS
|
$4.07M |
| 3 |
Marvell Technology
MRVL
|
$3.93M |
| 4 |
Applovin
APP
|
$3.87M |
| 5 |
BridgeBio Pharma
BBIO
|
$3.12M |
Top Sells
| 1 |
Apple
AAPL
|
$12.6M |
| 2 |
Palantir
PLTR
|
$12.2M |
| 3 |
Sprouts Farmers Market
SFM
|
$4.91M |
| 4 |
Hamilton Lane
HLNE
|
$3.86M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$3.53M |
Sector Composition
| 1 | Technology | 29.17% |
| 2 | Healthcare | 23.69% |
| 3 | Industrials | 13.65% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Williams-Sonoma
WSM
$23B
| $1.57M | 0.22% |
9,632
+3,585
| +59% | +$585K |
|
152
Archrock
AROC
$4.32B
| $1.41M | 0.2% |
+56,860
| New | +$1.41M |
|
|
OS
153
OneStream, Inc. Class A Common Stock
OS
$3.76B
| $1.41M | 0.2% |
+49,788
| New | +$1.41M |
|
154
Neurocrine Biosciences
NBIX
$14B
| $1.4M | 0.2% |
11,175
+1,026
| +10% | +$129K |
|
155
Inspire Medical Systems
INSP
$2.84B
| $1.39M | 0.2% |
+10,747
| New | +$1.39M |
|
156
Ibotta
IBTA
$754M
| $1.32M | 0.19% |
35,982
-273
| -0.8% | -$9.99K |
|
|
ONC
157
BeOne Medicines Ltd. American Depositary Shares
ONC
$39.1B
| $1.3M | 0.18% |
5,362
-2,258
| -30% | -$547K |
|
158
Viking Therapeutics
VKTX
$3.02B
| $1.29M | 0.18% |
48,708
-416
| -0.8% | -$11K |
|
159
Zoetis
ZTS
$67.8B
| $1.27M | 0.18% |
8,142
-4,736
| -37% | -$738K |
|
160
Credo Technology Group
CRDO
$21.3B
| $1.15M | 0.16% |
+12,449
| New | +$1.15M |
|
161
Waters Corp
WAT
$17.7B
| $873K | 0.12% |
2,499
-1,362
| -35% | -$476K |
|
162
MSCI
MSCI
$43B
| – | – |
-3,530
| Closed | -$2M |
|
163
Onto Innovation
ONTO
$5.08B
| – | – |
-26,067
| Closed | -$3.16M |
|
164
Parker-Hannifin
PH
$94.3B
| – | – |
-3,858
| Closed | -$2.34M |
|
165
Impinj
PI
$5.34B
| – | – |
-18,961
| Closed | -$1.72M |
|
166
Rocket Pharmaceuticals
RCKT
$359M
| – | – |
-110,961
| Closed | -$737K |
|
|
167
Sprouts Farmers Market
SFM
$13.6B
| – | – |
-32,144
| Closed | -$4.91M |
|
168
Spotify
SPOT
$140B
| – | – |
-4,884
| Closed | -$2.69M |
|
169
Spyre Therapeutics
SYRE
$1.02B
| – | – |
-82,472
| Closed | -$1.33M |
|
170
UnitedHealth
UNH
$281B
| – | – |
-2,849
| Closed | -$1.49M |
|
171
Vera Therapeutics
VERA
$1.4B
| – | – |
-109,281
| Closed | -$2.62M |
|
172
Weatherford International
WFRD
$4.53B
| – | – |
-42,117
| Closed | -$2.26M |
|
173
Rubrik
RBRK
$17.1B
| – | – |
-42,252
| Closed | -$2.58M |
|
|
174
Apple
AAPL
$3.41T
| – | – |
-56,780
| Closed | -$12.6M |
|
175
Asana
ASAN
$3.39B
| – | – |
-129,482
| Closed | -$1.89M |
|